BREAKING NEWS

Pfizer begins testing pneumococcal vaccine along with COVID booster shot

By REUTERS

MAY 24, 2021 14:19

Pfizer Inc said on Monday it has started immunizing the first patients in a new study looking at administering the company's 20-valent pneumococcal conjugate vaccine candidate following a booster dose of the Pfizer-BioNTech COVID-19 shot.

The study will include 600 adults over 65 years who will be recruited from the late-stage study of the Pfizer-BioNTech COVID-19 vaccine, and will have received their second dose of the vaccine at least six months prior to entering the co-administration study, the company said.

Ukraine urges swift global reaction to Russia's use of 'new weapon'

By REUTERS

11/21/2024 05:30 PM

Britain now 'directly involved' in Ukraine war, says Russian ambassador to UK

By REUTERS

11/21/2024 05:20 PM

IAF completes third series of strikes in Dahieh on Hezbollah structures

By JERUSALEM POST STAFF

11/21/2024 05:18 PM

Irish PM says ICC charges against Netanyahu and Hamas leader serious and significant

By REUTERS

11/21/2024 04:54 PM